Close
Biotechgate
| |

Home Page

Wright Medical Group N.V. to Present at 37th Annual J.P. Morgan Healthcare Conference
By: Nasdaq / GlobenewsWire - 10 Dec 2018Back to overview list

Monday, January 7, 2019 at 1:30 p.m. Pacific Time

AMSTERDAM, The Netherlands, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Wright Medical Group N.V. (NASDAQ: WMGI) announced today that it will present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019, at the Westin St. Francis Hotel in San Francisco, California.  Robert Palmisano, president and chief executive officer, will present at 1:30 p.m. Pacific Time.  

A live audio webcast of the conference presentation and the Q&A session, along with the accompanying presentation materials, will be available on Wright’s corporate website at www.wright.com, under the “Investors” link.  The audio webcast and accompanying presentation materials will be archived on this site under the “Investor Presentations” link following the conference.

Internet Posting of Information

Wright routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.wright.com.  The company encourages investors and potential investors to consult the Wright website regularly for important information about Wright.

About Wright Medical Group N.V.

Wright Medical Group N.V. is a global medical device company focused on extremities and biologics products. The company is committed to delivering innovative, value-added solutions improving the quality of life for patients worldwide.  Wright is a recognized leader of surgical solutions for the upper extremities (shoulder, elbow, wrist and hand), lower extremities (foot and ankle) and biologics markets, three of the fastest growing segments in orthopaedics.  For more information about Wright, visit www.wright.com

Investors & Media: 

Julie D. Dewey
Sr. Vice President, Chief Communications Officer
Wright Medical Group N.V.
(901) 290-5817
julie.dewey@wright.com

Related companies:Wright Medical Group N.V.
Copyright 2018 Nasdaq / GlobenewsWire Back to overview list
to the top ↑